HOME >> MEDICINE >> NEWS
UQ develops West Nile virus treatment

A University of Queensland researcher has developed the world's first specific immunotherapy product using monoclonal antibodies for the potentially lethal West Nile virus, which causes seasonal epidemics around the globe.

The mosquito-borne virus affects the central nervous systems of humans, horses and birds in North America, Africa, the Middle East and Europe.

Dr Roy Hall, from UQ's School of Molecular and Microbial Sciences, has developed an immunotherapy treatment for the disease based on a monoclonal antibody that binds to the benign Australian Kunjin virus.

The treatment completely neutralised the West Nile virus and provided infected mice protection against the onset of symptoms, according to Dr Hall.

"We also believe it may be possible to reverse the symptoms of West Nile in animals such as horses, and we're about to begin trials to test this theory, administering the treatment to animals in various stages of infection," Dr Hall said.

Recognising the potential of the treatment, international animal health product manufacturer, Fort Dodge Animal Health, has licensed Dr Hall's treatment via UQ's commercial arm, UniQuest Pty Ltd.

Fort Dodge will test the treatment's effectiveness in horses and develop it for commercial sale to the equine industry, according to UniQuest Managing Director, David Henderson.

"Horses are a large group affected by West Nile virus in the U.S., and Dr. Hall's treatment will complement Fort Dodge Animal Health's equine vaccine that protects against the disease," Mr Henderson said.

In addition, Dr Hall is developing a West Nile vaccine for humans with UQ's Associate Professor Alex Khromykh, which is undergoing preclinical trials. A West Nile diagnostic reagent also developed by Dr Hall has been licensed for sale in the U.S. and will be used to track the spread of the disease in animals and birds in North America.

Dr Hall said it was very satisfying to see h
'"/>

Contact: Julia Renaud
61-7-3365-4037
Research Australia
26-Apr-2005


Page: 1 2

Related medicine news :

1. How to lose weight and not go hungry: HU researcher develops drug that mimics feeling of fullness
2. Johns Hopkins develops pancreas cancer risk model
3. Washington University surgeon develops treatment for foot deformity
4. PhD researcher develops inexpensive, sustainable production method in just 2 years
5. UCLA develops unique nerve-stimulation epilepsy treatment
6. Alberta develops worlds first electronic surgical reporting
7. Researcher develops better way to detect shock
8. St. Jude develops more affordable ALL follow-up test
9. Colorectal cancer develops earlier in drinkers, smokers and men
10. UCLA develops new method to track neuron cell death leading to Alzheimers disease
11. UC Davis researchers shed new light on how chemotherapy-induced leukemia develops

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... (PRWEB) , ... July 22, ... ... additional investment to reduce the risks of infectious diseases for patients and ... disinfectant technologies, and expanding the infection prevention resources. This timely response is ...
(Date:7/18/2020)... ... July 17, 2020 , ... “Frozen.” It’s not simply the title ... – oftentimes for unknown reasons – resulting in stiffness, persistent pain and loss of ... in treating problems of the upper limbs and joints and founder and chief medical ...
(Date:7/18/2020)... ... July 18, 2020 , ... The Dentists, LLC is an established general dental ... 35 years. NJ Top Dentists, Dr. Georgette Bennardo-Meggelin and Dr. Aliza E. Staiman lead ... dentistry. , “We are committed to making our patients’ treatment comfortable and enjoyable. We ...
(Date:7/10/2020)... ... July 10, 2020 , ... Health and beauty ... offering, Liposuction 360 . The group, with offices located throughout Greater Los ... plastic surgeries and cosmetic procedures is an exciting new addition to the list ...
(Date:7/10/2020)... ... 2020 , ... Ziegler, a specialty investment bank, is pleased to announce the ... Hill at Eastgate (Beacon Hill). The Series 2020 Bank Bonds include a $9,800,000 ... amortization that will be retired with initial entrance fees from the Project (detailed below). ...
Breaking Medicine News(10 mins):
(Date:7/22/2020)... ... July 22, 2020 , ... TrialScope, the ... announce the addition of Moderna to its growing customer roster. , TrialScope customers ... for trial disclosure management, patient engagement and study recruitment. Collectively, TrialScope customers are ...
(Date:7/22/2020)... Pa. (PRWEB) , ... July 22, 2020 , ... ... agency for the nation’s top healthcare companies and part of WPP (NYSE:WPP), has ... Warren, EVP, Media Investment. , As the agency ventures further into healthcare consumer ...
(Date:7/10/2020)... ... July 10, 2020 , ... ... Lillian DeCosimo in partnership with Dr. Shashi Kusuma, a plastic surgeon, is introducing ... Suria Women’s Health division. This service/treatment is a first-of-its-kind specifically focused on female ...
Breaking Medicine Technology:
Cached News: